End-of-day quote
Taiwan S.E.
06:00:00 2024-04-28 pm EDT
|
5-day change
|
1st Jan Change
|
59.3
TWD
|
+1.89%
|
|
+0.17%
|
-24.17%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
7,937
|
7,203
|
6,512
|
15,840
|
9,663
|
9,197
|
Enterprise Value (EV)
1 |
9,825
|
8,539
|
8,308
|
17,748
|
10,660
|
9,171
|
P/E ratio
|
19.8
x
|
55.2
x
|
40.5
x
|
32
x
|
20.5
x
|
-84.1
x
|
Yield
|
3.5%
|
1.58%
|
1.71%
|
2.03%
|
3.28%
|
1.02%
|
Capitalization / Revenue
|
1.26
x
|
1.13
x
|
1.23
x
|
2.16
x
|
1.06
x
|
1.76
x
|
EV / Revenue
|
1.56
x
|
1.34
x
|
1.57
x
|
2.42
x
|
1.17
x
|
1.75
x
|
EV / EBITDA
|
12.8
x
|
18.1
x
|
17.2
x
|
20.5
x
|
12.3
x
|
42.9
x
|
EV / FCF
|
-9.28
x
|
9.39
x
|
-30.6
x
|
-15.9
x
|
12.6
x
|
24.6
x
|
FCF Yield
|
-10.8%
|
10.6%
|
-3.27%
|
-6.28%
|
7.94%
|
4.06%
|
Price to Book
|
2.25
x
|
2.13
x
|
2
x
|
3.31
x
|
1.93
x
|
1.7
x
|
Nbr of stocks (in thousands)
|
86,747
|
92,942
|
93,029
|
107,029
|
105,604
|
117,604
|
Reference price
2 |
91.50
|
77.50
|
70.00
|
148.0
|
91.50
|
78.20
|
Announcement Date
|
3/27/19
|
3/20/20
|
3/3/21
|
2/25/22
|
3/9/23
|
3/1/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
6,311
|
6,370
|
5,285
|
7,339
|
9,082
|
5,232
|
EBITDA
1 |
770
|
471.4
|
484
|
866.8
|
865.9
|
213.7
|
EBIT
1 |
555.6
|
240.6
|
216.3
|
584.4
|
582.8
|
-93.48
|
Operating Margin
|
8.8%
|
3.78%
|
4.09%
|
7.96%
|
6.42%
|
-1.79%
|
Earnings before Tax (EBT)
1 |
537.9
|
228
|
206.4
|
605.6
|
733.7
|
-64.95
|
Net income
1 |
393
|
128
|
155.2
|
462.9
|
493.2
|
-100.2
|
Net margin
|
6.23%
|
2.01%
|
2.94%
|
6.31%
|
5.43%
|
-1.92%
|
EPS
2 |
4.611
|
1.403
|
1.728
|
4.619
|
4.470
|
-0.9300
|
Free Cash Flow
1 |
-1,059
|
909.3
|
-271.4
|
-1,114
|
846.4
|
372.5
|
FCF margin
|
-16.78%
|
14.28%
|
-5.14%
|
-15.18%
|
9.32%
|
7.12%
|
FCF Conversion (EBITDA)
|
-
|
192.87%
|
-
|
-
|
97.75%
|
174.33%
|
FCF Conversion (Net income)
|
-
|
710.27%
|
-
|
-
|
171.63%
|
-
|
Dividend per Share
2 |
3.203
|
1.227
|
1.200
|
3.000
|
3.000
|
0.8000
|
Announcement Date
|
3/27/19
|
3/20/20
|
3/3/21
|
2/25/22
|
3/9/23
|
3/1/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
1,887
|
1,336
|
1,796
|
1,908
|
997
|
-
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
25.7
|
Leverage (Debt/EBITDA)
|
2.451
x
|
2.833
x
|
3.71
x
|
2.201
x
|
1.151
x
|
-
|
Free Cash Flow
1 |
-1,059
|
909
|
-271
|
-1,114
|
846
|
373
|
ROE (net income / shareholders' equity)
|
11.5%
|
3.73%
|
4.13%
|
9.5%
|
9.32%
|
-1.21%
|
ROA (Net income/ Total Assets)
|
5.31%
|
2.11%
|
1.91%
|
4.19%
|
3.39%
|
-0.55%
|
Assets
1 |
7,400
|
6,066
|
8,142
|
11,042
|
14,561
|
18,207
|
Book Value Per Share
2 |
40.60
|
36.40
|
35.00
|
44.70
|
47.30
|
46.00
|
Cash Flow per Share
2 |
6.190
|
8.420
|
7.570
|
17.80
|
29.10
|
23.60
|
Capex
1 |
783
|
372
|
484
|
432
|
541
|
699
|
Capex / Sales
|
12.42%
|
5.84%
|
9.15%
|
5.89%
|
5.96%
|
13.36%
|
Announcement Date
|
3/27/19
|
3/20/20
|
3/3/21
|
2/25/22
|
3/9/23
|
3/1/24
|
|
1st Jan change
|
Capi.
|
---|
| -24.17% | 210M | | +11.76% | 63.22B | | -3.51% | 46.34B | | +13.09% | 39.97B | | +19.36% | 25.46B | | +8.37% | 18.68B | | +1.44% | 17.24B | | -20.33% | 15.81B | | +0.36% | 14.9B | | -12.98% | 13.74B |
Other Specialty Chemicals
|